Ispecimen Inc. current report, Q4 FY2025

Business Context and Reporting Period

This Form 8-K Current Report from iSpecimen Inc. (Nasdaq: ISPC) covers events occurring on December 31, 2025, with the report filed on January 5, 2026. The filing primarily discloses the entry into a material definitive agreement and references a concurrent private placement of Series C Convertible Non-Voting Preferred Stock.

Key Financial Metrics

The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. Specific financial details disclosed include:

  • Consulting Fee: An aggregate cash fee of $2,000,000 payable to IR Agency LLC.
  • Funding Source: The fee was funded from a portion of the net proceeds of the Company's private placement of Series C Convertible Non-Voting Preferred Stock.
  • Debt and Liquidity: The filing text does not provide clear values for total debt, liquidity ratios, or cash balances.

Material Changes

The primary material change reported is the execution of a Consulting Agreement with IR Agency LLC effective December 31, 2025. Key terms include:

  • Services: Marketing, advertising, and investor communications services.
  • Term: Initial four-month term commencing December 31, 2025.
  • Payment Status: The $2,000,000 fee was deemed earned upon receipt and paid upon execution.
  • Termination: Either party may terminate the agreement at any time, with or without cause.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future financial performance. Risks and contingencies noted include:

  • Contractual Risk: The agreement is non-exclusive and terminable at will by either party.
  • Regulatory Compliance: The Consultant represented that it is not a broker-dealer or investment adviser and will not solicit investors or effect securities transactions, ensuring compliance with U.S. securities laws.

Investor Verification Checklist

  • Verify the total proceeds and terms of the Series C Convertible Non-Voting Preferred Stock private placement referenced in the filing.
  • Review the full text of the Consulting Agreement (Exhibit 10.1) for specific deliverables and performance metrics.
  • Confirm the impact of the $2,000,000 cash outflow on the Company's current liquidity position.
  • Monitor subsequent filings for any updates on the utilization of the remaining net proceeds from the private placement.